¡idiBELL Christmas and happy 2019!
Christmas card from Zoe López, a student of Institut Bellvitge
¡idiBELL Christmas and happy 2019! Read More »
2018
IDIBELL and Bellvitge University Hospital develop a new treatment to fight against hospital infections
The new treatment would prevent more than 4 million patients admitted to the Intensive Care Units (ICU) worldwide from developing infections that need antibiotics
An intellectually active lifestyle protects against neurodegeneration in people with Huntington’s disease
The discovery reinforces the importance of leading a cognitively stimulating life to maintain a healthy brain
Researchers identify a new therapeutic target for metastatic and resistant prostate cancers
Researchers identify a new therapeutic target for metastatic and resistant prostate cancers
Ruth Rodríguez Barrueco, L’Oréal-UNESCO Research Award “For Women in Science”
IDIBELL – University of Barcelona researcher Ruth Rodríguez Barrueco has been awarded one of the five L’Oréal-UNESCO Research Awards “For Women in Science” in its 2018-19 call. The award, worth € 15,000, will support and promote the project carried out by Dr. Rodríguez-Barrueco, which focuses on the discovery of new targets for breast cancer treatment. Breast
Ruth Rodríguez Barrueco, L’Oréal-UNESCO Research Award “For Women in Science” Read More »
The ‘Viladecans Against Cancer’ Association Coordinator raises 20.000 euros for research on metastasis of unknown origin cancer in IDIBELL
During the course of an open ‘paella’ that brought together eight hundred people in the Cúbic space of Viladecans, the Association Viladecans Against Cancer officially offered a 20,000 euros check to IDIBELL for the investigation of a new treatment for cancer metastasis of unknown origin, led by Dr. Manel Esteller (Epigenetics and Cancer Biology program
Scientists unveil the mechanism of action of the key gene for the formation of blood vessels involved in cancer and vascular malformations
The detailed description of the biology of the PIK3CA gene has allowed to understand how venous malformations and other overgrowth disorders, such as cancer, develop.
IDIBELL-ICO and VHIO public outreach to promote the importance of translational research in improving outcomes for patients with prostate cancer
Pioneered by Virgil H. Simons, Founder and President of the patient education and advocacy group The Prostate Net, an annual series of workshops and symposia aimed at increasing public awareness on and around the importance of cancer science and clinical discovery in advancing precision medicine cancer care for patients suffering from prostate cancer has just launched. Co-organized
The 4th edition of the charity sports day Sosciathlon collects € 18,000 for IDIBELL research
The association has made two donations of € 9,000 to the research groups of Dr. Miguel Gil and Dr. Jordi Guardiola, IDIBELL researchers and doctors from the Catalan Institute of Oncology and the Bellvitge University Hospital.
Occupational risk management at IDIBELL is recognized by MC MUTUAL “Antonio Baró” Awards
Occupational risk management at the Bellvitge Biomedical Research Institute (IDIBELL) has been awarded with an honorable mention by MC MUTUAL, a social security-linked mutual insurance company, within the XVII Edition of the MC MUTUAL “Antonio Baró” Awards for Occupational Risk Prevention, given to the companies, people and institutions that excel when it comes to effectively
Occupational risk management at IDIBELL is recognized by MC MUTUAL “Antonio Baró” Awards Read More »